Comparison studies of CellRx Short™AE-IGF-1 to competitive products
CellRx Limited (CellRx) is a manufacturer and supplier of growth factors that serve the technical research and bioprocessing markets. Our first product to market is Short AE-IGF-1, a well-characterized, high potency, competitively priced alternative to insulin and other insulin-like analogues. CellRx also offers a range of services to the bioprocessing industry including GMP contract manufacturing, bioprocess development and optimization.
CellRx Short AE-IGF-1 is available for laboratory research and large-scale in-vitro biopharmaceutical manufacturing use only. Not for diagnostic or therapeutic use.
Short™AE-IGF-1 is a registered trademark of CellRx Limited.